Global Sustained Release Excipients Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Product (Polymers, Minerals, Sugars, Gelatin & Chitosan), By Technology, By Regional Outlook and Forecast, 2022 - 2028

Global Sustained Release Excipients Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Product (Polymers, Minerals, Sugars, Gelatin & Chitosan), By Technology, By Regional Outlook and Forecast, 2022 - 2028

The Global Sustained Release Excipients Market size is expected to reach $1.9 billion by 2028, rising at a market growth of 8.4% CAGR during the forecast period.

Sustained release excipients are one form of excipient that is added in drugs along with its active pharmacological ingredients. Sustained release excipients are pharmacologically inactive components of the medication formulation. These are formulated with an active ingredient for the purposes of long-term stabilization, bulking up solid mixtures that contain powerful active components in small amounts.

These also refer to a therapeutic improvement on the active component in the concluding dosage form, such as enhancing solubility, facilitating drug absorption, or reducing viscosity. Excipients can also be helpful during the manufacturing process to help with concerns relating to the active substance, such as assisting powder flow properties or non-stick attributes.

Additionally, it supports in vitro stability, such as preventing aggregation or denaturation over the presumed shelf life. The dosage form, mode of administration, the active ingredient, and other variables all play a role in choosing the best excipients. Using polymer layers on solid dosage forms, adding various enzyme-activated systems, polymer matrix technologies, or systems that react to changes in physiological conditions inside the formulation can all result in sustained-release behavior.

Diffusion, dissolution, osmotic pressure, preserving a hydrodynamic or hydrologic equilibrium, and ion exchange are examples of mechanisms. New strategies are currently being explored focused on nanotechnology and innovative matrix technologies, and include buoyant systems, mucoadhesive systems, and gastro-retentive drug distribution for controlled release of antiviral drugs.

COVID - 19 Impact Analysis

Due to the closure of R&D and production facilities, the shortage of raw materials, and the lack of a possible workforce, resulting in a decrease in the total movement, including the creation of new items during the lockdown. The pandemic primarily complicated supply chain logistics, driving up the cost of producing different excipients, especially sustained-release excipients. The possibility of sustained release excipients for the production of the COVID-19 vaccine was also still being assessed at the time, taking up the opportunities for other drug development.

Market Growth Factors

Increased patient compliance leading to raised comfort

Patient compliance is one of the main issues faced by marketers of pharmaceutical products. A patient's willingness to take medication can significantly decline when it needs to be given multiple times each day, increasing the risk of inadequate treatment. Moreover, studies have stated that an incomplete treatment can aggravate the cause of the disease, leading to high chances of the patient succumbing to the disease again. In such cases of relapse, sometimes medicines become ineffective.

Rising disease and disorder prevalence and drug abuse

Globally, both acute and chronic diseases are becoming more common. Significant growth for medications is seen as a result of the rise in chronic disease prevalence. The increasing tendencies of side effects posed by drugs can lead to other problems. Abuse of substances has a significant negative influence on people's and their families’ health. Long-term drug and alcohol addiction can result in mental illness, chronic conditions including diabetes and heart disease, and cancer, all of which place a heavy financial cost on society.

Market Restraining Factors

Difficulties in formulations and maintaining API concentration

Attaining optimal dissolution and then release profiles for poor solubility medications, managing the danger of dose dumping, and choosing biocompatible substances with the required controlled-release qualities are only a few of the difficulties that formulators may encounter. High API concentrations, which can occasionally be challenging to manufacture into the appropriate dosage formulations with acceptable characteristics, are also needed for controlled-release pharmaceuticals.

Route of Administration Outlook

On the basis of route of administration, the sustained release excipients market is divided into oral, intramuscular, subcutaneous, transdermal, vaginal, ophthalmic, intravenous, and others. The oral route of administration procured the largest revenue share in the sustained release excipients market in 2021. It is the simplest and most used method of medication delivery. The availability of the highest active surface area enabling drug absorption in contrast to other drug delivery methods is one of the major causes behind the high share. Another significant element that contributes to the widespread adoption of oral drug delivery is the simplicity of producing tablets and capsules.

Product Outlook

Based on product, the sustained release excipients market is categorized into gelatin and chitosan, polymers, minerals, sugars, alcohol, and others. The mineral segment witnessed significant revenue share in the sustained release excipients market in 2021. An inorganic substance with a known chemical makeup is a mineral. Minerals can be highly developed products or naturally occurring components or compounds. Calcium carbonate, which is present in limestone, magnesium stearate, which is used as a lubricant, silicon dioxide, which is most frequently associated with beach sand, and many other substances are examples of minerals.

Technology Outlook

Based on technology, the sustained release excipients market is segmented into targeted delivery, micro encapsulation, wurster technique, transdermal, implants, coacervation, and others. The targeted delivery technology witnessed the maximum revenue share in the sustained release excipients market in 2021. Targeted delivery entails sending the medication to the desired site of activity and preventing it from going to the wrong portions of the body, which increases the risk of drug toxicity. Higher patient compliance is provided by sustained release drug delivery systems, and localization of the drug is made possible by targeted drug delivery technology.

Regional Outlook

On the basis of region, the sustained release excipients market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe region acquired the highest revenue share in the sustained release excipients market in 2021. Increased R&D efforts and the existence of significant pharmaceutical businesses in the area are credited with the region's success. Due to patent expiration dates and the subsequent entry of generics, it is predicted that the region will continue to grow over the forecast period at a profitable rate.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BASF SE, International Flavors & Fragrances, Inc., Ashland Global Holdings Inc., Evonik Industries AG, Croda International Plc, Gattefossé, Merck Group, Pfizer, Inc., Novartis AG and AstraZeneca Plc.

Strategies deployed in Sustained Release Excipients Market

2022-Mar: Evonik unveiled EUDRATEC SoluFlow, a new microparticle technology to improve the solubility of engaged pharmaceutical ingredients in oral drug products. The EUDRATEC SoluFlow is an emulsion-based process innovation that reduces solubility difficulties that cannot be handled by present production technologies. Since more than 70% of contemporary small molecules are insoluble, the product, therefore, encourages the development of novel oral therapeutics in various areas such as cancer, cardiovascular diseases, infectious diseases, and diabetes.

2021-Feb: Evonik partnered with BioNTech, a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Through this partnership, Evonik invested in the short-term elaboration of its specialty lipids manufacturing, which is critical for mRNA-based COVID-19 vaccines. The partnership allowed Evonik to participate in increasing the reserve security of the Pfizer-BioNTech COVID-19 vaccine.

2020-Nov: Croda partnered with Pfizer, a leading research-based biopharmaceutical company. Under this partnership, Croda would provide lipid-based excipients to Pfizer for the development of mRNA–based COVID-19 vaccine prospects. The inactive components would be manufactured by Avanti Polar Lipids, a high-purity lipids firm that Croda acquired earlier.

2020-Sep: Evonik acquired the Lactel business, a subsidiary of Durect Corporation. With this acquisition, Evonik aimed to bolster its in healthcare solutions and its position as a leading CDMO for drug delivery solutions throughout the world. The acquisition marked a prominent step in the development strategy of the life-science unit of nutrition & care of the company.

2020-Jul: Croda International took over Avanti Polar Lipids, a knowledge-intensive leader in lipid-based drug delivery technologies for next-generation pharmaceuticals. Through the acquisition, Croda strengthened its drug delivery expertise. Avanti's innovative methodology and expertise are supportive of Croda's abilities in drug delivery systems, vaccine adjuvants, and immunotherapy. The acquisition doubled Croda's research and development (R&D) credentials in drug delivery. Additionally, Avanti also supplied a medium to market Croda's components for initial-stage pharmaceutical study in both retail and academic organizations worldwide.

2020-Jun: Evonik introduced the RESOMER Precise platform. The platform equips custom functional polymeric excipients to enable pharmaceutical businesses to manage the release profile of their parenteral drug products to formerly unattainable level of precision and accuracy. The RESOMER platform is facilitated by exceptional and highly sophisticated process technology. The platform assists to optimize drug product resilience and thereby further lessens regulatory risk for a degree of complex parenteral drug products.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration

  • Oral
  • Transdermal
  • Vaginal
  • Intravenous
  • Ophthalmic
  • Subcutaneous
  • Intramuscular
  • Others
By Product
  • Polymers
  • Minerals
  • Sugars
  • Gelatin & Chitosan
  • Others
By Technology
  • Targeted Delivery
  • Implants
  • Wurster Technique
  • Transdermal
  • Micro Encapsulation
  • Coacervation & Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • BASF SE
  • International Flavors & Fragrances, Inc.
  • Ashland Global Holdings Inc.
  • Evonik Industries AG
  • Croda International Plc
  • Gattefossé
  • Merck Group
  • Pfizer, Inc.
  • Novartis AG
  • AstraZeneca Plc
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Sustained Release Excipients Market, by Route of Administration
1.4.2 Global Sustained Release Excipients Market, by Product
1.4.3 Global Sustained Release Excipients Market, by Technology
1.4.4 Global Sustained Release Excipients Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Sustained Release Excipients Market
Chapter 4. Global Sustained Release Excipients Market by Route of Administration
4.1 Global Oral Market by Region
4.2 Global Transdermal Market by Region
4.3 Global Vaginal Market by Region
4.4 Global Intravenous Market by Region
4.5 Global Ophthalmic Market by Region
4.6 Global Subcutaneous Market by Region
4.7 Global Intramuscular Market by Region
4.8 Global Others Market by Region
Chapter 5. Global Sustained Release Excipients Market by Product
5.1 Global Polymers Market by Region
5.2 Global Minerals Market by Region
5.3 Global Sugars Market by Region
5.4 Global Gelatin & Chitosan Market by Region
5.5 Global Others Market by Region
Chapter 6. Global Sustained Release Excipients Market by Technology
6.1 Global Targeted Delivery Market by Region
6.2 Global Implants Market by Region
6.3 Global Wurster Technique Market by Region
6.4 Global Transdermal Market by Region
6.5 Global Micro Encapsulation Market by Region
6.6 Global Coacervation & Others Market by Region
Chapter 7. Global Sustained Release Excipients Market by Region
7.1 North America Sustained Release Excipients Market
7.1.1 North America Sustained Release Excipients Market by Route of Administration
7.1.1.1 North America Oral Market by Country
7.1.1.2 North America Transdermal Market by Country
7.1.1.3 North America Vaginal Market by Country
7.1.1.4 North America Intravenous Market by Country
7.1.1.5 North America Ophthalmic Market by Country
7.1.1.6 North America Subcutaneous Market by Country
7.1.1.7 North America Intramuscular Market by Country
7.1.1.8 North America Others Market by Country
7.1.2 North America Sustained Release Excipients Market by Product
7.1.2.1 North America Polymers Market by Country
7.1.2.2 North America Minerals Market by Country
7.1.2.3 North America Sugars Market by Country
7.1.2.4 North America Gelatin & Chitosan Market by Country
7.1.2.5 North America Others Market by Country
7.1.3 North America Sustained Release Excipients Market by Technology
7.1.3.1 North America Targeted Delivery Market by Country
7.1.3.2 North America Implants Market by Country
7.1.3.3 North America Wurster Technique Market by Country
7.1.3.4 North America Transdermal Market by Country
7.1.3.5 North America Micro Encapsulation Market by Country
7.1.3.6 North America Coacervation & Others Market by Country
7.1.4 North America Sustained Release Excipients Market by Country
7.1.4.1 US Sustained Release Excipients Market
7.1.4.1.1 US Sustained Release Excipients Market by Route of Administration
7.1.4.1.2 US Sustained Release Excipients Market by Product
7.1.4.1.3 US Sustained Release Excipients Market by Technology
7.1.4.2 Canada Sustained Release Excipients Market
7.1.4.2.1 Canada Sustained Release Excipients Market by Route of Administration
7.1.4.2.2 Canada Sustained Release Excipients Market by Product
7.1.4.2.3 Canada Sustained Release Excipients Market by Technology
7.1.4.3 Mexico Sustained Release Excipients Market
7.1.4.3.1 Mexico Sustained Release Excipients Market by Route of Administration
7.1.4.3.2 Mexico Sustained Release Excipients Market by Product
7.1.4.3.3 Mexico Sustained Release Excipients Market by Technology
7.1.4.4 Rest of North America Sustained Release Excipients Market
7.1.4.4.1 Rest of North America Sustained Release Excipients Market by Route of Administration
7.1.4.4.2 Rest of North America Sustained Release Excipients Market by Product
7.1.4.4.3 Rest of North America Sustained Release Excipients Market by Technology
7.2 Europe Sustained Release Excipients Market
7.2.1 Europe Sustained Release Excipients Market by Route of Administration
7.2.1.1 Europe Oral Market by Country
7.2.1.2 Europe Transdermal Market by Country
7.2.1.3 Europe Vaginal Market by Country
7.2.1.4 Europe Intravenous Market by Country
7.2.1.5 Europe Ophthalmic Market by Country
7.2.1.6 Europe Subcutaneous Market by Country
7.2.1.7 Europe Intramuscular Market by Country
7.2.1.8 Europe Others Market by Country
7.2.2 Europe Sustained Release Excipients Market by Product
7.2.2.1 Europe Polymers Market by Country
7.2.2.2 Europe Minerals Market by Country
7.2.2.3 Europe Sugars Market by Country
7.2.2.4 Europe Gelatin & Chitosan Market by Country
7.2.2.5 Europe Others Market by Country
7.2.3 Europe Sustained Release Excipients Market by Technology
7.2.3.1 Europe Targeted Delivery Market by Country
7.2.3.2 Europe Implants Market by Country
7.2.3.3 Europe Wurster Technique Market by Country
7.2.3.4 Europe Transdermal Market by Country
7.2.3.5 Europe Micro Encapsulation Market by Country
7.2.3.6 Europe Coacervation & Others Market by Country
7.2.4 Europe Sustained Release Excipients Market by Country
7.2.4.1 Germany Sustained Release Excipients Market
7.2.4.1.1 Germany Sustained Release Excipients Market by Route of Administration
7.2.4.1.2 Germany Sustained Release Excipients Market by Product
7.2.4.1.3 Germany Sustained Release Excipients Market by Technology
7.2.4.2 UK Sustained Release Excipients Market
7.2.4.2.1 UK Sustained Release Excipients Market by Route of Administration
7.2.4.2.2 UK Sustained Release Excipients Market by Product
7.2.4.2.3 UK Sustained Release Excipients Market by Technology
7.2.4.3 France Sustained Release Excipients Market
7.2.4.3.1 France Sustained Release Excipients Market by Route of Administration
7.2.4.3.2 France Sustained Release Excipients Market by Product
7.2.4.3.3 France Sustained Release Excipients Market by Technology
7.2.4.4 Russia Sustained Release Excipients Market
7.2.4.4.1 Russia Sustained Release Excipients Market by Route of Administration
7.2.4.4.2 Russia Sustained Release Excipients Market by Product
7.2.4.4.3 Russia Sustained Release Excipients Market by Technology
7.2.4.5 Spain Sustained Release Excipients Market
7.2.4.5.1 Spain Sustained Release Excipients Market by Route of Administration
7.2.4.5.2 Spain Sustained Release Excipients Market by Product
7.2.4.5.3 Spain Sustained Release Excipients Market by Technology
7.2.4.6 Italy Sustained Release Excipients Market
7.2.4.6.1 Italy Sustained Release Excipients Market by Route of Administration
7.2.4.6.2 Italy Sustained Release Excipients Market by Product
7.2.4.6.3 Italy Sustained Release Excipients Market by Technology
7.2.4.7 Rest of Europe Sustained Release Excipients Market
7.2.4.7.1 Rest of Europe Sustained Release Excipients Market by Route of Administration
7.2.4.7.2 Rest of Europe Sustained Release Excipients Market by Product
7.2.4.7.3 Rest of Europe Sustained Release Excipients Market by Technology
7.3 Asia Pacific Sustained Release Excipients Market
7.3.1 Asia Pacific Sustained Release Excipients Market by Route of Administration
7.3.1.1 Asia Pacific Oral Market by Country
7.3.1.2 Asia Pacific Transdermal Market by Country
7.3.1.3 Asia Pacific Vaginal Market by Country
7.3.1.4 Asia Pacific Intravenous Market by Country
7.3.1.5 Asia Pacific Ophthalmic Market by Country
7.3.1.6 Asia Pacific Subcutaneous Market by Country
7.3.1.7 Asia Pacific Intramuscular Market by Country
7.3.1.8 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Sustained Release Excipients Market by Product
7.3.2.1 Asia Pacific Polymers Market by Country
7.3.2.2 Asia Pacific Minerals Market by Country
7.3.2.3 Asia Pacific Sugars Market by Country
7.3.2.4 Asia Pacific Gelatin & Chitosan Market by Country
7.3.2.5 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Sustained Release Excipients Market by Technology
7.3.3.1 Asia Pacific Targeted Delivery Market by Country
7.3.3.2 Asia Pacific Implants Market by Country
7.3.3.3 Asia Pacific Wurster Technique Market by Country
7.3.3.4 Asia Pacific Transdermal Market by Country
7.3.3.5 Asia Pacific Micro Encapsulation Market by Country
7.3.3.6 Asia Pacific Coacervation & Others Market by Country
7.3.4 Asia Pacific Sustained Release Excipients Market by Country
7.3.4.1 China Sustained Release Excipients Market
7.3.4.1.1 China Sustained Release Excipients Market by Route of Administration
7.3.4.1.2 China Sustained Release Excipients Market by Product
7.3.4.1.3 China Sustained Release Excipients Market by Technology
7.3.4.2 Japan Sustained Release Excipients Market
7.3.4.2.1 Japan Sustained Release Excipients Market by Route of Administration
7.3.4.2.2 Japan Sustained Release Excipients Market by Product
7.3.4.2.3 Japan Sustained Release Excipients Market by Technology
7.3.4.3 India Sustained Release Excipients Market
7.3.4.3.1 India Sustained Release Excipients Market by Route of Administration
7.3.4.3.2 India Sustained Release Excipients Market by Product
7.3.4.3.3 India Sustained Release Excipients Market by Technology
7.3.4.4 South Korea Sustained Release Excipients Market
7.3.4.4.1 South Korea Sustained Release Excipients Market by Route of Administration
7.3.4.4.2 South Korea Sustained Release Excipients Market by Product
7.3.4.4.3 South Korea Sustained Release Excipients Market by Technology
7.3.4.5 Singapore Sustained Release Excipients Market
7.3.4.5.1 Singapore Sustained Release Excipients Market by Route of Administration
7.3.4.5.2 Singapore Sustained Release Excipients Market by Product
7.3.4.5.3 Singapore Sustained Release Excipients Market by Technology
7.3.4.6 Malaysia Sustained Release Excipients Market
7.3.4.6.1 Malaysia Sustained Release Excipients Market by Route of Administration
7.3.4.6.2 Malaysia Sustained Release Excipients Market by Product
7.3.4.6.3 Malaysia Sustained Release Excipients Market by Technology
7.3.4.7 Rest of Asia Pacific Sustained Release Excipients Market
7.3.4.7.1 Rest of Asia Pacific Sustained Release Excipients Market by Route of Administration
7.3.4.7.2 Rest of Asia Pacific Sustained Release Excipients Market by Product
7.3.4.7.3 Rest of Asia Pacific Sustained Release Excipients Market by Technology
7.4 LAMEA Sustained Release Excipients Market
7.4.1 LAMEA Sustained Release Excipients Market by Route of Administration
7.4.1.1 LAMEA Oral Market by Country
7.4.1.2 LAMEA Transdermal Market by Country
7.4.1.3 LAMEA Vaginal Market by Country
7.4.1.4 LAMEA Intravenous Market by Country
7.4.1.5 LAMEA Ophthalmic Market by Country
7.4.1.6 LAMEA Subcutaneous Market by Country
7.4.1.7 LAMEA Intramuscular Market by Country
7.4.1.8 LAMEA Others Market by Country
7.4.2 LAMEA Sustained Release Excipients Market by Product
7.4.2.1 LAMEA Polymers Market by Country
7.4.2.2 LAMEA Minerals Market by Country
7.4.2.3 LAMEA Sugars Market by Country
7.4.2.4 LAMEA Gelatin & Chitosan Market by Country
7.4.2.5 LAMEA Others Market by Country
7.4.3 LAMEA Sustained Release Excipients Market by Technology
7.4.3.1 LAMEA Targeted Delivery Market by Country
7.4.3.2 LAMEA Implants Market by Country
7.4.3.3 LAMEA Wurster Technique Market by Country
7.4.3.4 LAMEA Transdermal Market by Country
7.4.3.5 LAMEA Micro Encapsulation Market by Country
7.4.3.6 LAMEA Coacervation & Others Market by Country
7.4.4 LAMEA Sustained Release Excipients Market by Country
7.4.4.1 Brazil Sustained Release Excipients Market
7.4.4.1.1 Brazil Sustained Release Excipients Market by Route of Administration
7.4.4.1.2 Brazil Sustained Release Excipients Market by Product
7.4.4.1.3 Brazil Sustained Release Excipients Market by Technology
7.4.4.2 Argentina Sustained Release Excipients Market
7.4.4.2.1 Argentina Sustained Release Excipients Market by Route of Administration
7.4.4.2.2 Argentina Sustained Release Excipients Market by Product
7.4.4.2.3 Argentina Sustained Release Excipients Market by Technology
7.4.4.3 UAE Sustained Release Excipients Market
7.4.4.3.1 UAE Sustained Release Excipients Market by Route of Administration
7.4.4.3.2 UAE Sustained Release Excipients Market by Product
7.4.4.3.3 UAE Sustained Release Excipients Market by Technology
7.4.4.4 Saudi Arabia Sustained Release Excipients Market
7.4.4.4.1 Saudi Arabia Sustained Release Excipients Market by Route of Administration
7.4.4.4.2 Saudi Arabia Sustained Release Excipients Market by Product
7.4.4.4.3 Saudi Arabia Sustained Release Excipients Market by Technology
7.4.4.5 South Africa Sustained Release Excipients Market
7.4.4.5.1 South Africa Sustained Release Excipients Market by Route of Administration
7.4.4.5.2 South Africa Sustained Release Excipients Market by Product
7.4.4.5.3 South Africa Sustained Release Excipients Market by Technology
7.4.4.6 Nigeria Sustained Release Excipients Market
7.4.4.6.1 Nigeria Sustained Release Excipients Market by Route of Administration
7.4.4.6.2 Nigeria Sustained Release Excipients Market by Product
7.4.4.6.3 Nigeria Sustained Release Excipients Market by Technology
7.4.4.7 Rest of LAMEA Sustained Release Excipients Market
7.4.4.7.1 Rest of LAMEA Sustained Release Excipients Market by Route of Administration
7.4.4.7.2 Rest of LAMEA Sustained Release Excipients Market by Product
7.4.4.7.3 Rest of LAMEA Sustained Release Excipients Market by Technology
Chapter 8. Company Profiles
8.1 BASF SE
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 International Flavors & Fragrances, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segment & Regional Analysis
8.2.4 Research & Development Expense
8.3 Ashland Global Holdings Inc. (Pharmachem Laboratories Inc.)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.4 Evonik Industries AG (RAG-Stiftung)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.5 Croda International PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Merck Group
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Pfizer, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional & Segmental Analysis
8.7.4 Research & Development Expense
8.8 Novartis AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 AstraZeneca PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.10. Gattefossé
8.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings